(1-Methyl-1H-pyrazol-3-yl)methanamine – (612511-81-6)

2'-Fluoro-2'-deoxyadenosine, 64183-27-3, 2'-Deoxy-2'-fluoroadenosine, Adenosine, 2'-deoxy-2'-fluoro-, (2R, 3R, 4R, 5R)-5-(6-aminopurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol, (2R, 3R, 4R, 5R)-5-(6-Amino-9H-purin-9-yl)-4-fluoro-2-(hydroxymethyl)tetrahydrofuran-3-ol, MFCD09750859, CHEMBL309579, 2 inverted exclamation marka-Deoxy-2 inverted exclamation marka-fluoroadenosine, NSC 274941, C10H12FN5O3, 9-(2-Fluoro-2-deoxy-beta-D-ribofuranosyl)-purin-6-amine, 2'F-dA, SCHEMBL237404, 5'-FDA, DTXSID60982712, ZGYYPTJWJBEXBC-QYYRPYCUSA-N, BDBM50144932, HG1028, AKOS015900907, AC-9552, HY-W039442, ND02827, (2R, 3R, 4R, 5R)-5-(6-aminopurin-9-yl)-4-fluoro-2-(hydroxymethyl)tetrahydrofuran-3-ol, AS-49376, BP-58852, PD158370, CS-0097284, 2'-BETA-FLUORO-2', 3'-DEOXYADENOSINE, 9-(2-Deoxy-2-fluoro-beta-D-ribofuranosyl)adenine, 6-Amino-9-(2-deoxy-2-fluoro-beta-D-ribofuranosyl)-9H-purine, (2R, 3R, 4R, 5R)-4-Fluoro-2-hydroxymethyl-5-(6-methylamino-purin-9-yl)-tetrahydro-furan-3-ol, 2'-Fluoro-2'-deoxy-D-adenosine 9-(2-Fluoro-2-deoxy-?-D-ribofuranosyI)-ad enine 2'-Deoxy-2'-fluoro-D-adenosine 2'-Fluoro-2'-deoxyadenosine, 814-045-6